港股異動丨上海復旦暴漲逾20% 上海自貿試驗區正積極洽談集成電路相關外資項目
格隆匯2月24日丨上海復旦(1385.HK)暴漲逾20%,報7.35港元,成交1815萬港元,總市值51億港元。據中證報,上海自貿試驗區臨港新片區管委會專職副主任吳曉華24日在上海市政府新聞發佈會上表示,臨港新片區積極主動運用“互聯網+招商”的方式,通過不見面談判,抓緊項目簽約落地,努力把疫情對新片區造成的影響降到最低。吳曉華表示,2月13日,臨港新片區如期進行了12個項目、總投資200億元的線上簽約,這批項目集中在以5G為代表的第三代半導體材料設計工藝領域,同時還有一批人工智能、集成電路等有影響力的外資項目在積極洽談過程中。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.